Industry › BioTech

Press Releases

아방스 클리니컬, 고객 가치 리더십 부문에서 프로스트&설리번 2021 아시아-태평양 CRO 최고기업상 수상

Aug 12, 2021 16:30 HKT/SGT

エーザイ、「レンビマ(R)」と「キイトルーダ(R)」の併用療法による成人の進行性腎細胞がん一次治療に関する承認を米国FDAより取得

Aug 12, 2021 09:00 JST

FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for First-Line Treatment of Adult Patients with Advanced Renal Cell Carcinoma (RCC)

Aug 12, 2021 08:31 HKT/SGT

四环医药 (0460.HK)：响应医美专项整治，倡导中国医美“正能量”

Aug 11, 2021 16:57 HKT/SGT

四環醫藥 (0460.HK)：響應醫美專項整治，倡導中國醫美「正能量」

Aug 11, 2021 16:56 HKT/SGT

Sihuan Pharmaceutical (0460.HK): Respond to the special directives to combat illegal medical aesthetics services, Advocate 'Positive Energy' in China's Medical Aesthetics Industry

Aug 11, 2021 16:55 HKT/SGT

Avance Clinical 荣获 Frost & Sullivan 2021 年亚太地区 CRO 最佳实践奖，以表彰其客户价值领导力

Aug 11, 2021 07:00 HKT/SGT

Avance Clinical 榮獲 Frost & Sullivan 2021 年亞太地區 CRO 最佳實踐獎，以表彰其客戶價值領導力

Aug 11, 2021 07:00 HKT/SGT

Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership

Aug 10, 2021 14:00 HKT/SGT

冠科美博（APOLLOMICS）APL-102 中国I期临床研究完成首例患者给药

Aug 10, 2021 11:55 HKT/SGT

冠科美博（APOLLOMICS）APL-102 中國I期臨床研究完成首例患者給藥

Aug 10, 2021 11:54 HKT/SGT

AMDL, a Subsidiary of China Biotech Services, is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including China

Aug 10, 2021 10:29 HKT/SGT

렌질루맙 치료제, 인공 호흡기 없는 상황에서 아프리카계 미국인 코로나19 입원 환자들의 생존률을 높일 것으로 예상

Aug 09, 2021 08:00 HKT/SGT

Hydrogel holds life-giving cells longer

Aug 06, 2021 23:00 HKT/SGT

エーザイ、第37回企業広報賞「企業広報大賞」を受賞

Aug 06, 2021 10:00 JST

미국 국립보건원, 코로나-19 치료용 렌질루맙의 ACTIV-5/BET-B 임상 평가 임상 2상에서 임상 2/3상 진척

Aug 05, 2021 16:00 HKT/SGT

Eisai Receives Award for Excellence in Corporate Communications at the 37th Corporate Communications Awards

Aug 05, 2021 10:45 HKT/SGT

エーザイ、第37回企業広報賞「企業広報大賞」を受賞

Aug 05, 2021 09:00 JST

Eisai's Anti-Epileptic Drug Fycompa Approved In China As Monotherapy For Partial-Onset Seizures And Pediatric Indication For Partial-Onset Seizures

Aug 02, 2021 11:24 HKT/SGT

エーザイ、抗てんかん剤「フィコンパ(R)」が中国において部分てんかんの単剤療法および小児適応に係る承認を取得

Aug 02, 2021 09:00 JST